Find uplifting stories about heroes, innovations, and solutions
6312 results for "vaccine manufacturing"
African nations are building their own vaccine production systems after being left at the back of the line during global health crises. A $1.2 billion initiative and new manufacturing hubs are turning dependence into self-reliance.
Africa is taking bold steps to produce its own medicines and vaccines, aiming to manufacture 60% locally by 2040 while fixing health financing gaps that force families into poverty. The continent's health leaders are tackling inefficiencies that waste millions and leave people paying for healthcare out of pocket.
Malaysia will manufacture its own human vaccine for the first time in 2028, ending total reliance on imports and securing health independence. The COVID-19 pandemic showed why making life-saving medicine at home matters.
Egypt is teaming up with pharmaceutical giant Pfizer to manufacture vaccines and medicines right at home, reducing dependence on imports and strengthening healthcare for millions. The partnership could transform how the nation delivers critical treatments to its people.
Ghana is developing a regulatory framework to become West Africa's vaccine manufacturing hub, reducing the continent's dependence on imported medicines. The move comes after COVID-19 exposed how vulnerable African nations are when global supply chains break down.
Scientists at Harvard have created a new DNA origami vaccine that works as well as mRNA shots but doesn't need freezers and is simpler to manufacture. The breakthrough could make life-saving vaccines accessible to millions more people worldwide.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
Egypt's health ministry is teaming up with pharmaceutical giant Pfizer to expand cancer treatment, improve care for hemophilia patients, and manufacture vaccines locally. The partnership could transform healthcare access for millions across the nation.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
A new Ebola vaccine developed in just eight weeks has been given to its first human volunteer, with 600,000 doses already manufactured and ready to deploy. The experimental vaccine targets a deadly Ebola strain currently spreading in the Democratic Republic of Congo.
African researchers are racing to develop the continent's first chikungunya vaccine designed specifically for children and local populations. Rwanda is leading a four-year, $17 million partnership across four African nations to test and eventually manufacture the life-saving vaccine.
Abu Dhabi is teaming up with global pharmaceutical company Sanofi to build a cutting-edge Vaccine Innovation Centre powered by artificial intelligence and mRNA technology. The facility will combine research, manufacturing, and pandemic preparedness under one roof to accelerate life-saving vaccine development.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
The same groundbreaking technology that created COVID vaccines just earned approval for fighting the flu. Moderna's new mRNA flu shot showed better protection than standard vaccines and will be available for the 2026-2027 flu season.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
Showing 20 of 6312